RECENT NEWS

SARSTEDT was the winner of the Best Stand Award at the IBMS Congress 2025, held at ICC Birmingham. Sponsored by Pro-Lab Diagnostics and BIVDA, the award recognises excellence in exhibition design, visitor engagement, and innovation in biomedical sciences.

Dr Riina Richardson, one of the UK’s leading experts in fungal infections, has been elected the next President of the British Society for Medical Mycology (BSMM) – one of the oldest specialist societies for human and animal fungal disease in the world.

A new independent report by the International Pandemic Preparedness Secretariat (IPPS), the Brown University Pandemic Center and FIND, the global alliance for diagnostics, has identified persistent barriers in diagnostic preparedness that continue to undermine efforts to prevent future pandemics.

The new Moderna Innovation and Technology Centre, which will develop and manufacture mRNA vaccines, has been officially opened by Health and Social Care Secretary Wes Streeting.

Alpenglow Biosciences, a leader in AI-powered 3D pathology, has announced a strategic agreement with Virdx, a biophysics AI company focused on MRI-based cancer detection, with the two firms collaborating to accelerate the development of tools that bridge radiology and pathology.

Countable Labs has announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction.

The International Association for the Study of Lung Cancer (IASLC) Pathology Committee has proposed a simple, prognostically relevant grading system for resected invasive LUSC based on tumour budding, in a newly published study.

Pathways to Antimicrobial Clinical Efficacy (PACE) has recently launched its third funding round, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health.

Ataraxis AI, a frontier laboratory developing artificial intelligence–powered prognostic tools for oncology, and Medica Scientia Innovation Research (MEDSIR), a global leader in oncology research, have announced a strategic collaboration to integrate AI into multiple major international trials.

Gestalt has announced the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform.

The time it takes to approve clinical trials in the UK has been cut by more than half – from an average of 91 days to just 41 days – following major reforms backed by new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), new research has confirmed.

Breath biopsy firm Owlstone Medical has announced that it has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop its POSEIDON programme to enable accurate, low-cost, accessible cancer screening.

The UK Sepsis Trust has commissioned and is fully funding a new study, led by the University of St Andrews, which aims to improve sepsis diagnosis and lead to lifesaving interventions.

Swedish firm Inify Laboratories, which offers prostate cancer diagnostics, has chosen Milton Park in Oxfordshire as the site for its first UK laboratory.

Revvity has announced a programme for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi, as well as a new laboratory-developed test to expand clinical testing for early-stage disease screening.

Leica Biosystems has launched two new software solutions into its Aperio Digital Pathology portfolio.

Proscia is introducing virtual staining in its Concentriq software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows.

A pioneering ‘cloud-based’ AI research screening platform, funded by the National Institute for Health and Care Research (NIHR) will enable NHS trusts across the country to join Al trials aiming to help speed up diagnosis.

The Department of Health and Social Care says the NHS will move from a ‘cheapest-first’ to a ‘patient-first’ approach to purchasing medical technology, as it aims to cut waiting lists and save money in the long term.

The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organisation that advances the use of validated AI solutions in clinical practice, has announced that Epredia has won three categories in the ISB awards.